nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—CFTR—sclerosing cholangitis	0.88	1	CbGaD
Bumetanide—SLC10A1—bile canaliculus—sclerosing cholangitis	0.0381	0.32	CbGeAlD
Bumetanide—CFTR—ventral pancreatic duct—sclerosing cholangitis	0.0211	0.177	CbGeAlD
Bumetanide—CFTR—sweat—sclerosing cholangitis	0.0211	0.177	CbGeAlD
Bumetanide—SLC10A1—bile duct—sclerosing cholangitis	0.0119	0.0999	CbGeAlD
Bumetanide—SLC10A1—bile—sclerosing cholangitis	0.00914	0.0768	CbGeAlD
Bumetanide—CFTR—gall bladder—sclerosing cholangitis	0.00306	0.0257	CbGeAlD
Bumetanide—CA9—gall bladder—sclerosing cholangitis	0.00264	0.0222	CbGeAlD
Bumetanide—CFTR—pancreas—sclerosing cholangitis	0.00141	0.0118	CbGeAlD
Bumetanide—CA5A—liver—sclerosing cholangitis	0.00133	0.0111	CbGeAlD
Bumetanide—SLC12A2—pancreas—sclerosing cholangitis	0.00124	0.0104	CbGeAlD
Bumetanide—SLC12A4—liver—sclerosing cholangitis	0.00114	0.00958	CbGeAlD
Bumetanide—CFTR—liver—sclerosing cholangitis	0.000897	0.00753	CbGeAlD
Bumetanide—CA5B—pancreas—sclerosing cholangitis	0.000809	0.00679	CbGeAlD
Bumetanide—SLC12A2—liver—sclerosing cholangitis	0.000788	0.00661	CbGeAlD
Bumetanide—SLC10A1—liver—sclerosing cholangitis	0.000744	0.00625	CbGeAlD
Bumetanide—PTGS2—gall bladder—sclerosing cholangitis	0.000742	0.00623	CbGeAlD
Bumetanide—CA14—liver—sclerosing cholangitis	0.000736	0.00618	CbGeAlD
Bumetanide—SLC22A11—liver—sclerosing cholangitis	0.000679	0.00571	CbGeAlD
Bumetanide—SLC22A7—liver—sclerosing cholangitis	0.000663	0.00557	CbGeAlD
Bumetanide—SLCO1A2—liver—sclerosing cholangitis	0.000401	0.00337	CbGeAlD
Bumetanide—PTGS2—pancreas—sclerosing cholangitis	0.000342	0.00287	CbGeAlD
Bumetanide—SLC10A1—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.0003	0.264	CbGpPWpGaD
Bumetanide—PTGS2—liver—sclerosing cholangitis	0.000217	0.00183	CbGeAlD
Bumetanide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—sclerosing cholangitis	0.00012	0.106	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	5.67e-05	0.0498	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	5.67e-05	0.0498	CbGpPWpGaD
Bumetanide—CA9—Cellular response to hypoxia—HIF1A—sclerosing cholangitis	5.3e-05	0.0466	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	4.82e-05	0.0424	CbGpPWpGaD
Bumetanide—PTGS2—Eicosanoid Synthesis—GGT1—sclerosing cholangitis	3.04e-05	0.0267	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	2.87e-05	0.0252	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	2.44e-05	0.0214	CbGpPWpGaD
Bumetanide—CA9—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	2.22e-05	0.0195	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	1.98e-05	0.0174	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	1.71e-05	0.015	CbGpPWpGaD
Bumetanide—PTGS2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	1.69e-05	0.0148	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	1.55e-05	0.0136	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	1.5e-05	0.0132	CbGpPWpGaD
Bumetanide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	1.42e-05	0.0125	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	1.3e-05	0.0115	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ABCB4—sclerosing cholangitis	1.25e-05	0.011	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ABCB4—sclerosing cholangitis	1.22e-05	0.0107	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	1.16e-05	0.0102	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ABCB4—sclerosing cholangitis	1.14e-05	0.01	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ABCB4—sclerosing cholangitis	1.14e-05	0.01	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	1.09e-05	0.00957	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	1.07e-05	0.00944	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ABCB4—sclerosing cholangitis	1.05e-05	0.00927	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	9.74e-06	0.00856	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ABCB4—sclerosing cholangitis	8.81e-06	0.00775	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ABCB4—sclerosing cholangitis	8.41e-06	0.00739	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	8.12e-06	0.00713	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—HIF1A—sclerosing cholangitis	8.05e-06	0.00707	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ABCB4—sclerosing cholangitis	6.79e-06	0.00597	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GOT2—sclerosing cholangitis	5.94e-06	0.00522	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	5.88e-06	0.00517	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GOT2—sclerosing cholangitis	5.79e-06	0.00509	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GOT2—sclerosing cholangitis	5.41e-06	0.00475	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GOT2—sclerosing cholangitis	5.41e-06	0.00475	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—NOS2—sclerosing cholangitis	5.37e-06	0.00472	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GGT1—sclerosing cholangitis	5.13e-06	0.00451	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GOT1—sclerosing cholangitis	5.13e-06	0.00451	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GOT2—sclerosing cholangitis	5.01e-06	0.0044	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GGT1—sclerosing cholangitis	5e-06	0.00439	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GOT1—sclerosing cholangitis	5e-06	0.00439	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GGT1—sclerosing cholangitis	4.67e-06	0.0041	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GOT1—sclerosing cholangitis	4.67e-06	0.0041	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GOT1—sclerosing cholangitis	4.67e-06	0.0041	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GGT1—sclerosing cholangitis	4.67e-06	0.0041	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCB4—sclerosing cholangitis	4.34e-06	0.00381	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GOT1—sclerosing cholangitis	4.32e-06	0.0038	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GGT1—sclerosing cholangitis	4.32e-06	0.0038	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GOT2—sclerosing cholangitis	4.19e-06	0.00368	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GOT2—sclerosing cholangitis	3.99e-06	0.00351	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	3.99e-06	0.00351	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GOT1—sclerosing cholangitis	3.61e-06	0.00318	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GGT1—sclerosing cholangitis	3.61e-06	0.00318	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GGT1—sclerosing cholangitis	3.45e-06	0.00303	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GOT1—sclerosing cholangitis	3.45e-06	0.00303	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GOT2—sclerosing cholangitis	3.23e-06	0.00284	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GGT1—sclerosing cholangitis	2.79e-06	0.00245	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GOT1—sclerosing cholangitis	2.79e-06	0.00245	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCB4—sclerosing cholangitis	2.62e-06	0.0023	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	2.41e-06	0.00212	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GOT2—sclerosing cholangitis	2.06e-06	0.00181	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GGT1—sclerosing cholangitis	1.78e-06	0.00156	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GOT1—sclerosing cholangitis	1.78e-06	0.00156	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GOT2—sclerosing cholangitis	1.49e-06	0.00131	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GOT1—sclerosing cholangitis	1.28e-06	0.00113	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GOT2—sclerosing cholangitis	1.24e-06	0.00109	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GGT1—sclerosing cholangitis	1.07e-06	0.000944	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GOT1—sclerosing cholangitis	1.07e-06	0.000944	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HIF1A—sclerosing cholangitis	8.92e-07	0.000784	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS2—sclerosing cholangitis	8.12e-07	0.000713	CbGpPWpGaD
